Reports their earnings in about 3 weeks and I expect another beat and what I am most keen about hearing is whether or not they turn a profit in this quarter, right now they are just on the cusp of turning a profit, with -0.25% profit margin, any improvement in this quarter and that flips to green, with the introduction of the GLP drug, I suspect it was a strong quarter too.
We could start to see a run up to earnings now shortly, I would like to see a higher high next above $22 to show the trend is now moving up to complete Subwave 5 of Wave 3.